MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells
2011

miR-21 in Angiogenesis

publication 10 minutes Evidence: moderate

Author Information

Author(s): Sabatel Céline, Malvaux Ludovic, Bovy Nicolas, Deroanne Christophe, Lambert Vincent, Gonzalez Maria-Luz Alvarez, Colige Alain, Rakic Jean-Marie, Noël Agnès, Martial Joseph A., Struman Ingrid

Primary Institution: University of Liège

Hypothesis

miR-21 acts as a negative regulator of angiogenesis by targeting RhoB expression in endothelial cells.

Conclusion

The study identifies miR-21 as a new angiogenesis inhibitor that reduces endothelial cell migration and tubulogenesis through repression of RhoB.

Supporting Evidence

  • miR-21 overexpression reduced endothelial cell proliferation and migration.
  • miR-21 inhibition led to increased endothelial cell migration and tube formation.
  • RhoB was identified as a direct target of miR-21, linking it to angiogenesis regulation.
  • Therapeutic potential of miR-21 was demonstrated in a mouse model of choroidal neovascularization.

Takeaway

This study shows that a tiny molecule called miR-21 can stop blood vessel growth by making it harder for cells to move and form new tubes.

Methodology

The study used in vitro angiogenic assays and in vivo mouse models to assess the effects of miR-21 on endothelial cell functions.

Limitations

The study primarily focuses on a single miRNA and its effects, which may not encompass the full complexity of angiogenesis regulation.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016979

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication